Boston based AZTherapies is a Boston-based life science company targeting neuroinflammation and developing novel therapies to treat neurodegenerative diseases. AZTherapies Announces Closing of $33.6 Million Series C-1 Financing Building Upon Recent $37.5 Million Series C Financing https://aztherapies.com/